These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31563290)

  • 21. Abdominal sonographic study of autosomal dominant polycystic kidney disease.
    Nicolau C; Torra R; Bianchi L; Vilana R; Gilabert R; Darnell A; Brú C
    J Clin Ultrasound; 2000; 28(6):277-82. PubMed ID: 10867665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.
    Eroglu E; Kocyigit I; Cetin M; Zararsiz G; Imamoglu H; Bayramov R; Tastan S; Sipahioglu MH; Tokgoz B; Oymak O
    Clin Exp Nephrol; 2019 Oct; 23(10):1188-1195. PubMed ID: 31165946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
    Sans L; Radosevic A; Quintian C; Montañés R; Gràcia S; Vilaplana C; Mojal S; Ballarin JA; Fernández-Llama P; Torra R; Pascual J
    PLoS One; 2017; 12(3):e0174583. PubMed ID: 28346513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
    Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
    J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
    van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
    Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genotype-phenotype correlation in ADPKD: a possible role for NGAL?].
    Virzì GM; Gastaldon F; Corradi V; de Cal M; Cruz DN; Clementi M; Ronco C
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24941494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
    Bae KT; Shi T; Tao C; Yu ASL; Torres VE; Perrone RD; Chapman AB; Brosnahan G; Steinman TI; Braun WE; Srivastava A; Irazabal MV; Abebe KZ; Harris PC; Landsittel DP;
    J Am Soc Nephrol; 2020 Jul; 31(7):1640-1651. PubMed ID: 32487558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of kidney disease varies between families with defects in the polycystic kidney disease type 1 gene in eastern Finland.
    Lumiaho A; Ikäheimo R; Pihlajamäki J; Miettinen R; Niemitukia L; Vanninen R; Lampainen E; Laakso M
    Scand J Urol Nephrol; 2003; 37(4):352-8. PubMed ID: 12944197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.
    Neijenhuis MK; Kievit W; Perrone RD; Sloan JA; Erwin P; Murad MH; Gevers TJG; Hogan MC; Drenth JPH
    BMC Nephrol; 2017 May; 18(1):169. PubMed ID: 28545401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral cysts in the choroid plexus in a patient with autosomal dominant polycystic kidney disease.
    Casteleijn NF; Spithoven EM; Rookmaaker MB; Vergouwen MD; Gansevoort RT
    Nephrol Dial Transplant; 2015 May; 30(5):859-60. PubMed ID: 25104083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.
    O'Sullivan DA; Torres VE; Gabow PA; Thibodeau SN; King BF; Bergstralh EJ
    Am J Kidney Dis; 1998 Dec; 32(6):976-83. PubMed ID: 9856513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary biomarkers at early ADPKD disease stage.
    Petzold K; Poster D; Krauer F; Spanaus K; Andreisek G; Nguyen-Kim TD; Pavik I; Ho TA; Serra AL; Rotar L
    PLoS One; 2015; 10(4):e0123555. PubMed ID: 25875363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research progress in autosomal dominant polycystic kidney disease].
    Hu S; Li D; Tan X; Gu J; Chen M; Zhang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 44(10):1179-1187. PubMed ID: 31857514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.